Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients

[1]  C. Cooper,et al.  Social inequality and fractures—secular trends in the Danish population: a case-control study , 2018, Osteoporosis International.

[2]  M. Jerkeman,et al.  Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114 patients with diffuse large B‐cell lymphoma , 2018, American journal of hematology.

[3]  A. Zimran,et al.  Bone loss and hematological malignancies in adults: a pilot study , 2018, Supportive Care in Cancer.

[4]  E. Siris,et al.  Hip fracture trends in the United States, 2002 to 2015 , 2018, Osteoporosis International.

[5]  S. Silverman,et al.  Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS , 2018, Osteoporosis International.

[6]  C. M. Madsen,et al.  Temporal trends in hip fracture incidence, mortality, and morbidity in Denmark from 1999 to 2012 , 2018, Acta orthopaedica.

[7]  Janet E Brown,et al.  Cancer Treatment and Bone Health , 2018, Calcified Tissue International.

[8]  Qi Shi,et al.  Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis , 2017, Oncotarget.

[9]  M. Javaid,et al.  Costs of fragility hip fractures globally: a systematic review and meta-regression analysis , 2017, Osteoporosis International.

[10]  M. Bøgsted,et al.  R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients , 2017, Leukemia & lymphoma.

[11]  F. Grodstein,et al.  Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project , 2017, Journal of internal medicine.

[12]  S. Fosså,et al.  Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation , 2017, Acta oncologica.

[13]  I. Saltvedt,et al.  One-year health and care costs after hip fracture for home-dwelling elderly patients in Norway: Results from the Trondheim Hip Fracture Trial , 2016, Scandinavian journal of public health.

[14]  Piet Geusens,et al.  Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. , 2016, Bone.

[15]  S. Norgren,et al.  Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics. , 2016, The Journal of clinical endocrinology and metabolism.

[16]  J. Kanis,et al.  The Effect of Latitude on the Risk and Seasonal Variation in Hip Fracture in Sweden , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  S. Gomez,et al.  Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. , 2014, Blood.

[18]  Y. Katayama,et al.  Regulation of hematopoiesis in endosteal microenvironments , 2014, International Journal of Hematology.

[19]  P. Fardellone,et al.  Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. , 2014, Annals of Oncology.

[20]  R. Baron,et al.  Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. , 2013, Blood.

[21]  C. Cooper,et al.  A systematic review of hip fracture incidence and probability of fracture worldwide , 2012, Osteoporosis International.

[22]  W. Leslie,et al.  Trends in Hip Fracture Rates in Canada , 2009 .

[23]  W. Leslie,et al.  Trends in hip fracture rates in Canada. , 2009, JAMA.

[24]  Xianglin L. Du,et al.  Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures , 2007, Leukemia & lymphoma.

[25]  T. Staa.  The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis , 2006, Calcified Tissue International.

[26]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[28]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2000 .

[29]  J. Pfeilschifter,et al.  Osteoporosis due to cancer treatment: pathogenesis and management. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Reid,et al.  Bone mineral density (BMD) in patients with lymphoma: The effects of chemotherapy, intermittent corticosteroids and premature menopause , 1992, Hematological oncology.

[31]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.